Analystreport

Iovance Biotherapeutics Inc (NASDAQ: IOVA) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $45.00 price target on the stock.

Iovance Biotherapeutics, Inc.  (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com